Novotech's innovative full-service approach accelerates clinical development with advanced analytics, diverse global patient access, and specialized technology.

SAN ANTONIO, Oct. 14, 2024 /PRNewswire/ -- Frost & Sullivan recently conducted an in-depth analysis of the biotech contract research organization (CRO) industry and based on its findings, has awarded Novotech the 2024 Global Company of the Year Award. As a leading global full-service CRO with over 25 years of experience, Novotech specializes in providing comprehensive early- to late-phase clinical development services tailored to biotech companies.